C. Busch Et Al. , "Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results," ACTA DIABETOLOGICA , vol.56, no.12, pp.1341-1350, 2019
Busch, C. Et Al. 2019. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. ACTA DIABETOLOGICA , vol.56, no.12 , 1341-1350.
Busch, C., Fraser-Bell, S., Iglicki, M., Lupidi, M., Couturier, A., Chaikitmongkol, V., ... Giancipoli, E.(2019). Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. ACTA DIABETOLOGICA , vol.56, no.12, 1341-1350.
Busch, Catharina Et Al. "Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results," ACTA DIABETOLOGICA , vol.56, no.12, 1341-1350, 2019
Busch, Catharina Et Al. "Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results." ACTA DIABETOLOGICA , vol.56, no.12, pp.1341-1350, 2019
Busch, C. Et Al. (2019) . "Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results." ACTA DIABETOLOGICA , vol.56, no.12, pp.1341-1350.
@article{article, author={Catharina Busch Et Al. }, title={Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results}, journal={ACTA DIABETOLOGICA}, year=2019, pages={1341-1350} }